While enteral nutrition remains foundational, its efficacy appears contingent on metabolic health status, underscoring the imperative for combinatorial approaches targeting insulin signaling, inflammation, and mitochondrial function in high-risk MetS populations. Here, INS is linked to metabolic syndrome.